Medicines Discovery & Development division members
We are a team of academics working on advancing human health through innovative medicines.
Through both prevention and cure, our research in drug discovery and advanced therapeutics addresses the major health challenges of our times. We integrate chemistry, biology, pharmacology and formulation science to create small molecules, peptides and biologics, uncover their mechanisms, and improve delivery. We address cancer, neurodegeneration, autoimmunity, infection and antimicrobial resistance, while advancing nanomedicine, biomaterials and targeted delivery.
Focus areas:
Find out more about our members and their research.
We are a team of academics working on advancing human health through innovative medicines.
Read news and updates from our Division.
Up to one-quarter of vapes confiscated in secondary schools in England contain the dangerous synthetic drug ‘spice’, according to a new study led by Bath.
University of Bath researchers briefed MPs and Peers during Evidence Week, highlighting the threat of synthetic drugs in vapes and the need for stronger action.
Dr Scott Lovell has been awarded a UKRI Future Leaders Fellowship, which provides up to seven years of funding to support outstanding early-career researchers.
New drug discovery technology harnesses bacteria to do the hard work of medicinal chemistry by creating drug candidates and testing them inside living cells.
Our research in drug discovery and advanced therapeutics tackles major health challenges through prevention and cure. We unite medicinal chemistry, structural biology, pharmacology, and formulation science to create new medicines and optimise delivery. We develop small molecules, peptides, and biologics, uncover their mechanisms, and advance technologies for barriers, personalised medicine, and diseases including cancer, neurodegeneration, autoimmunity, infection, and antimicrobial resistance.
If you have any questions about our research division, please contact us.